505 - 516 of 7723 results

Finding an Appropriate Treatment for Anne

Industry Podcast Sponsored by Eisai Inc; Not for CME/CE Credit


0.5 CME CREDIT

In this clinical coffee break, cardiologist Ty Gluckman and endocrinologist Archana Sadhu will explain why glucagon like peptide-1 receptor agonists (GLP-1 RA) are becoming increasingly prominent in diabetes algorithms and cardiovascular risk reduction. Faculty will review the clinical trial data on this class of medications as well as the mechanisms by which GLP-1 RA provide cardiovascular benefit. You will have the opportunity to engage with this activity, viewing resources and testing your knowledge with interactive questions and cases.


Doctor speaking with patient in military fatigues
1 CME CREDIT

Updates on Treatment of Atopic Dermatitis for the Primary Care Clinician (Module 2)

An Interactive Learning Experience from AmplifireThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.50 AANP | 0.50 Pharmacology


Diagnosing Moderate-to-Severe Atopic Dermatitis
1 CME CREDIT

More Than Just an Itch: Diagnosing Moderate-to-Severe Atopic Dermatitis (Module 1)

An Interactive Learning Experience from AmplifireThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.42 AANP


1 CME CREDIT

Anxiety During COVID-19: When to Intervene

1.00 CME/MOC
1.00 AANP | 0.33 Pharmacology

This session will discuss anxiety during COVID-19. The faculty will review how to diagnose an anxiety disorder and when (and how) to intervene with both behavioral and pharmacologic treatment recommendations. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 9/11/2020, and they are subject to change as new information is published.


1 CME CREDIT

1 CME CREDIT

Dermatology A-Z: A Refresher for Primary Care

1.00 CME/MOC
1.00 AANP | 0.50 Pharmacology

There have been many recent advances in the medical management of dermatologic disease. This session will cover the diagnosis and management of common skin disorders and provide an update on diagnosis and therapeutics. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 9/12/2020, and they are subject to change as new information is published.


1 CME CREDIT

Nutrition is essential to the prevention and treatment of chronic diseases. In this panel based discussion, the roles of diets and their limitations in clinical practice will be reviewed based on scientific evidence. You will learn about how individual responses and personalized meal plans are the key to success. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 9/12/2020, and they are subject to change as new information is published.


1 CME CREDIT

Every year, one in ten people worldwide experience a foodborne infection caused by a broad range of pathogens, from common enteric viruses and bacteria to less familiar parasites. There are many factors influencing the modern burden of foodborne illness: our increasingly global food supply, the ongoing changes in food production, consumer tastes, food safety practices, the growing number of vulnerable and/or immunosuppressed hosts, and even climate change. This talk will summarize the modern ecology of foodborne disease, describe the clinical presentation of common foodborne pathogens and update you several foodborne parasites currently emerging in the United States. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 9/12/2020, and they are subject to change as new information is published.


1.5 CME CREDITS

Heart failure (HF) affects more than 6 million Americans with approximately 50% mortality at 5 years. This session will show how recent advances in heart failure treatment have contributed to improved survival. This session will also discuss the guidelines, supporting evidence, and interventions to maximize hypertension management for individual patients. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 9/10/2020, and they are subject to change as new information is published.